Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Skinmed ; 22(1): 35-39, 2024.
Article in English | MEDLINE | ID: mdl-38494613

ABSTRACT

Individuals with psoriatic nails often have a lower quality of life relative to their counterparts with healthy nails. Methotrexate (MTX), an anti-neoplastic agent, is a longstanding treatment option for nail psoriasis. In the current study, we compared the effects of MTX to that of a corticosteroid, namely, methylprednisolone acetate (i.e., Depo-Medrol®) across individuals with nail psoriasis. We used a cohort study design, and both agents were administered intralesionally. Outcome variables were based on the Nail Psoriasis Severity Index (NAPSI). We quantified the effect in terms of change in NAPSI, complete cure at week 16, and cure between 32 and 36 weeks. Our regressions demonstrated that reduced NAPSI scores with Depo-Medrol were, on average, greater than that with MTX by 2.27 (n = 48, P = 0.000255) at week 16. Similarly, the odds of complete cure at week 16 was greater with Depo-Medrol® than with MTX (odds ratio = 18.6, P < 0.0001). In terms of both complete cure and change in NAPSI, Depo-Medrol® was significantly more effective than MTX at a follow-up period of 32-36 weeks. Our study established that intralesional Depo-Medrol® is more effective than intralesional methotrexate for treating nail psoriasis.


Subject(s)
Nail Diseases , Nails, Malformed , Psoriasis , Humans , Methotrexate/therapeutic use , Nails , Methylprednisolone Acetate , Cohort Studies , Quality of Life , Psoriasis/drug therapy , Nail Diseases/drug therapy , Severity of Illness Index
2.
Exp Dermatol ; 31(4): 567-576, 2022 04.
Article in English | MEDLINE | ID: mdl-34787924

ABSTRACT

BACKGROUND: Psoriasis is characterized by aberrant activation of several pro-inflammatory circuits as well as abnormal hyperproliferation and dysregulated apoptosis of keratinocytes (KCs). Most currently available therapeutic options primarily target psoriasis-associated immunological defects rather than epidermal abnormalities. OBJECTIVE: To investigate the efficacy of the histone deacetylase (HDAC) inhibitor, Vorinostat, in targeting hyperproliferation and impaired apoptosis in psoriatic skin. METHODS: Vorinostat effect was investigated in primary KCs cell cultures using cell cycle analysis by flow cytometry, apoptosis assays (Annexin V-FICH and caspase-3/7) and antibody arrays, qRT-PCR and immunohistochemistry. Vorinostat impact on clinical manifestations of psoriasis was investigated in a chimeric mouse model. RESULTS: Vorinostat was found to inhibit KCs proliferation and to induce their differentiation and apoptosis. Using a chimeric mouse model, vorinostat was found to result in marked attenuation of a psoriasiform phenotype with a significant decrease in epidermal thickness and inhibition of epidermal proliferation. CONCLUSIONS: Our results support the notion that vorinostat, a prototypic HDAC inhibitor, may be of potential use in the treatment of psoriasis and other hyperproliferative skin disorders.


Subject(s)
Histone Deacetylase Inhibitors , Psoriasis , Animals , Apoptosis , Cell Line, Tumor , Cell Proliferation , Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylase Inhibitors/therapeutic use , Mice , Psoriasis/drug therapy , Vorinostat/pharmacology , Vorinostat/therapeutic use
3.
Eur J Haematol ; 103(4): 335-341, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31278876

ABSTRACT

BACKGROUND: Chronic lymphocytic leukemia (CLL) is frequently accompanied by immune dysregulation. AIMS: In this multicenter prospective study, we investigated whether heavy + light chains (HLC: IgGκ, IgGλ, IgAκ, IgAκ, IgMκ, IgMλ) and IgG subclasses (IgG1, IgG2, IgG3, and IgG4) could be used as novel prognostic markers of immunoparesis in 105 treatment-naïve patients with CLL. RESULTS: Heavy + light chains immunoparesis of ≥1, ≥2, and ≥3 isotypes was evident in 74 (70%), 58 (55%), and 36 (34%) patients, respectively. Severe HLC immunoparesis was identified in 40 (38%) patients. Of the IgG subclasses, IgG1 and IgG2 were most frequently suppressed, affecting 46 (44%) and 36 (34%) patients, respectively; 63 (60%) patients had low levels of at least one IgG subclass. In multivariate analysis, severe HLC immunoparesis (hazard ratio [HR]: 36.5; P = .010) and ΣFLC ≥ 70 mg/L (HR: 13.2; P = .004) were the only factors independently associated with time to first treatment (TTFT). A risk model including these variables identified patients with 0, 1, and 2 risk factors and significantly different TTFT (P < .001). Patients with two factors represented an ultra-high-risk group with a median TTFT of only 1.3 months. CONCLUSION: The above findings demonstrate the potential for the use of HLC immunoparesis, together with sFLC measurements, as future prognostic biomarkers in CLL.


Subject(s)
Immunoglobulin Heavy Chains/blood , Immunoglobulin Light Chains/blood , Leukemia, Lymphocytic, Chronic, B-Cell/blood , Leukemia, Lymphocytic, Chronic, B-Cell/epidemiology , Aged , Aged, 80 and over , Biomarkers , Female , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Leukemia, Lymphocytic, Chronic, B-Cell/therapy , Male , Middle Aged , Models, Theoretical , Prognosis , Proportional Hazards Models , Time-to-Treatment
5.
Mol Biol Cell ; 20(16): 3751-62, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19553470

ABSTRACT

MAL, a compact hydrophobic, four-transmembrane-domain apical protein that copurifies with detergent-resistant membranes is obligatory for the machinery that sorts glycophosphatidylinositol (GPI)-anchored proteins and others to the apical membrane in epithelia. The mechanism of MAL function in lipid-raft-mediated apical sorting is unknown. We report that MAL clusters formed by two independent procedures-spontaneous clustering of MAL tagged with the tandem dimer DiHcRED (DiHcRED-MAL) in the plasma membrane of COS7 cells and antibody-mediated cross-linking of FLAG-tagged MAL-laterally concentrate markers of sphingolipid rafts and exclude a fluorescent analogue of phosphatidylethanolamine. Site-directed mutagenesis and bimolecular fluorescence complementation analysis demonstrate that MAL forms oligomers via xx intramembrane protein-protein binding motifs. Furthermore, results from membrane modulation by using exogenously added cholesterol or ceramides support the hypothesis that MAL-mediated association with raft lipids is driven at least in part by positive hydrophobic mismatch between the lengths of the transmembrane helices of MAL and membrane lipids. These data place MAL as a key component in the organization of membrane domains that could potentially serve as membrane sorting platforms.


Subject(s)
Membrane Lipids/metabolism , Membrane Microdomains/chemistry , Membrane Transport Proteins/metabolism , Myelin Proteins/metabolism , Proteolipids/metabolism , Animals , COS Cells , Chlorocebus aethiops , Glycosylphosphatidylinositols/chemistry , Glycosylphosphatidylinositols/genetics , Glycosylphosphatidylinositols/metabolism , Humans , Membrane Lipids/chemistry , Membrane Microdomains/metabolism , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/genetics , Models, Molecular , Mutagenesis, Site-Directed , Myelin Proteins/chemistry , Myelin Proteins/genetics , Myelin and Lymphocyte-Associated Proteolipid Proteins , Protein Conformation , Proteolipids/chemistry , Proteolipids/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
6.
Biochem Biophys Res Commun ; 351(3): 689-94, 2006 Dec 22.
Article in English | MEDLINE | ID: mdl-17081498

ABSTRACT

The secretory membrane system is comprised of membrane-bound organelles defined by specific sets of proteins that function in sequential modification of cargo proteins and lipids. This processing of cargo proteins and lipids is coupled to their secretory transport. Here, we investigated the effect of inhibiting N-glycan processing by swainsonine, an inhibitor of Golgi alpha1,2-mannosidase-II, on secretory transport of the thermo-reversible tsO45 mutant of vesicular stomatitis virus glycoprotein tagged with green fluorescent protein (VSVG-FP). Quantitative analysis using kinetic modeling combined with live cell imaging was used to derive the rate coefficients that delineate secretory transport of VSVG-FP. We found that neither inhibition of N-glycan processing nor elimination by mutagenesis of the first of the two asparagine-linked glycans had any significant effect on the rate of VSVG-FP transport through the Golgi. These data suggest that at least for VSVG, the multi-enzymatic process of N-glycan modification does not comprise a rate-limiting step for its Golgi efflux.


Subject(s)
Exocytosis/physiology , Golgi Apparatus/metabolism , Membrane Glycoproteins/metabolism , Models, Biological , Viral Envelope Proteins/metabolism , Animals , COS Cells , Chlorocebus aethiops , Computer Simulation , Kinetics , Metabolic Clearance Rate , Protein Transport/physiology , Protein Transport/radiation effects
7.
Mol Membr Biol ; 23(3): 245-57, 2006.
Article in English | MEDLINE | ID: mdl-16785208

ABSTRACT

Differential solubilization of membrane components by cold 1% Triton X-100 extraction is common practice in cell biology and membrane research, used to define components of, or localization within membrane domains called lipid rafts. In this study, extraction of biological membranes was continuously monitored in single cells by confocal microscopy. The distributions of fluorescently-tagged proteins that label raft and non-raft membranes, cytosolic and cytoskeletal proteins were continuously monitored upon addition of the detergent. Membranes containing the non-raft membrane protein VSVG-GFP were immediately extracted from the plasma membrane, whereas raft-membrane proteins were predominantly resistant to the detergent. The morphological characteristics of differential membrane solubilization consisted of the formation of pores that expand and percolate as the detergent-mediated solubilization proceeds. Pore expansion and percolation was much slower and more restricted in non-polarized MDCK cells than in COS-7 cells. Heterologous overexpression in COS-7 cells of the fluorescently-tagged human MAL, a tetra-spanning, lipid-raft-associated protein, significantly slowed and limited membrane pore expansion and percolation. Extensive percolation resulting in large holes in the membrane was observed for the raft-associated, GPI-GFP-labeled membranes in COS-7 cells. Quantitative analysis carried out using pixel intensity variance as an indicator of membrane pore expansion demonstrated that the MAL protein is capable of modifying the plasma membrane, thereby increasing its resistance to detergent-induced pore formation.


Subject(s)
Detergents/pharmacology , Membrane Microdomains/drug effects , Membrane Microdomains/metabolism , Membrane Transport Proteins/pharmacology , Myelin Proteins/pharmacology , Proteolipids/pharmacology , Animals , COS Cells , Cell Membrane/metabolism , Cells, Cultured , Chlorocebus aethiops , Fluorescent Dyes/metabolism , Glycosylphosphatidylinositols/metabolism , Humans , Microscopy, Confocal , Models, Biological , Myelin and Lymphocyte-Associated Proteolipid Proteins , Octoxynol/pharmacology , Porins/metabolism , Solubility , Transfection
8.
J Cell Sci ; 118(Pt 8): 1577-86, 2005 Apr 15.
Article in English | MEDLINE | ID: mdl-15784681

ABSTRACT

An outcome of overloading of the endoplasmic reticulum (ER) folding machinery is a perturbation in ER function and the formation of intracellular aggregates. The latter is a key pathogenic factor in numerous diseases known as ER storage diseases. Here, we report that heterologous overexpression of the green fluorescent protein-tagged iodide transporter pendrin (GFP-PDS) perturbs folding and degradation processes in the ER. Pendrin (PDS) is a chloride-iodide transporter found in thyroid cells. Mutations in PDS can cause its retention in the ER and are associated with Pendred syndrome. Biochemical and live-cell analyses demonstrated that wild-type GFP-PDS is predominantly retained in perinuclear aggregates and in ER membranes, causing their collapse and vesiculation. Inhibition of protein synthesis by cycloheximide (CHX) or puromycin caused dissociation of the GFP-PDS aggregates and returned the ER to its normal reticular morphology. Blocking protein synthesis promoted folding and export of ER-retained GFP-PDS, as demonstrated by surface-biotinylation analysis and by CHX- or puromycin-induced accumulation of YFP-PDS in the Golgi apparatus during a 20 degrees C temperature-block experiment. The chemical chaperone trimethylamine-N-oxide (TMAO) also reversed the GFP-PDS-mediated ER collapse and vesiculation, suggesting that exposed hydrophobic stretches of misfolded or aggregated GFP-PDS may contribute to ER retention. These data suggest that GFP-PDS is a slow-folding protein with a propensity to form aggregates when overexpressed. Thus, we describe a system for the reversible induction of ER stress that is based entirely on the heterologous overexpression of GFP-PDS.


Subject(s)
Endoplasmic Reticulum/metabolism , Membrane Transport Proteins/metabolism , Methylamines/pharmacology , Protein Folding , Protein Synthesis Inhibitors/pharmacology , Animals , COS Cells , Chlorocebus aethiops , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Endoplasmic Reticulum/drug effects , Golgi Apparatus/metabolism , Green Fluorescent Proteins , Humans , Intracellular Membranes/metabolism , Membrane Transport Proteins/genetics , Metabolic Diseases/metabolism , Metabolic Diseases/physiopathology , Oxidants/pharmacology , Protein Transport/drug effects , Protein Transport/physiology , Recombinant Fusion Proteins/metabolism , Stress, Physiological/metabolism , Stress, Physiological/physiopathology , Sulfate Transporters , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...